Skip to content
Solar Jackpot Base

Users Coming Off Weight-Loss Injections Regain Pounds Far More Rapidly Than People Using Diet and Exercise

Image of medical injection and weighing machine
Obesity treatment often requires ongoing approaches.

New research reveals that patients who come off new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who stop conventional diet and exercise plans.

Published data in a major medical journal shows that while overweight people can lose a large proportion of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit.

"People using these treatments need to be cognizant of the potential of fast weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

Such speed of regain implies a return to starting weight within about 18 months.

Weighing Treatments

The research, which looked at dozens of studies involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with conventional dieting.

Scientists point out that individuals who shed pounds through lifestyle changes alone generally experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Fast Regain

Experts believe the mode of action of the drugs explains the heightened rebound.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating much more probable."

A Lifelong Condition?

Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.

A number of clinicians argue that, due to the significant potential of weight regain, the treatment should be considered long-term.

This perspective is echoed by drug manufacturers, who note that the findings "highlight the chronic character of excess weight," akin to managing conditions like hypertension.

Patient Testimonies

People who have stopped the medication describe a intense resurgence of hunger.

"It felt as if a trigger that goes on and I was suddenly ravenous," said a patient.

This challenge is exacerbated if individuals have not adopted sustainable dietary or behavioural changes during treatment.

Significant Use

Figures indicate that millions of people in the UK have tried these injections in the past year, with desire continuing to grow.

  • Use is higher among females than men.
  • The middle-aged age group shows the highest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss hinges on integrated behavioural support.

SB
By

Sarah Barrett

Elara is a renewable energy consultant with over a decade of experience in solar technology and sustainable development, passionate about eco-friendly innovations.

Solar Jackpot Base

Type to search articles.